ASCO 2012 Live Blog – Sunday
CHICAGO (TheStreet) –Welcome to TheStreet’s live-blog coverage of the American Society of Clinical Oncology (ASCO) annual meeting. It’s Sunday, the second full day of data presentations at the largest annual gathering of cancer drug researchers in the world.
On the schedule for today: ASCO’s big plenary session, highlighting some of the most newsworthy clinical data at the conference. Roche and ImmunoGen are in the plenary spotlight this year with data from the phase III study of T-DM1 in breast cancer. Also sharing the plenary stage is a study combining Roche’s Rituxan with Teva’s Treanda in lymphoma. …
Click to view a price quote on RHHBY.
See the article here: ASCO 2012 Live Blog — Sunday